RPRX logo

Royalty Pharma plc (RPRX) Accounts Payable

Annual Accounts Payable:

$13.37M-$1.79M(-11.84%)
December 31, 2024

Summary

  • As of today, RPRX annual accounts payable is $13.37 million, with the most recent change of -$1.79 million (-11.84%) on December 31, 2024.
  • During the last 3 years, RPRX annual accounts payable has risen by +$7.75 million (+137.90%).
  • RPRX annual accounts payable is now -11.84% below its all-time high of $15.16 million, reached on December 31, 2023.

Performance

RPRX Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Quarterly Accounts Payable:

$41.41M+$21.21M(+104.93%)
September 30, 2025

Summary

  • As of today, RPRX quarterly accounts payable is $41.41 million, with the most recent change of +$21.21 million (+104.93%) on September 30, 2025.
  • Over the past year, RPRX quarterly accounts payable has increased by +$19.36 million (+87.78%).
  • RPRX quarterly accounts payable is now at all-time high.

Performance

RPRX Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

RPRX Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-11.8%+87.8%
3Y3 Years+137.9%+157.0%
5Y5 Years+19.6%+69.8%

RPRX Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-11.8%+137.9%at high+613.0%
5Y5-Year-11.8%+137.9%at high+636.9%
All-TimeAll-Time-11.8%>+9999.0%at high+636.9%

RPRX Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$41.41M(+104.9%)
Jun 2025
-
$20.21M(-46.3%)
Mar 2025
-
$37.63M(+181.5%)
Dec 2024
$13.37M(-11.8%)
$13.37M(-39.4%)
Sep 2024
-
$22.05M(-5.8%)
Jun 2024
-
$23.42M(+102.7%)
Mar 2024
-
$11.55M(-23.8%)
Dec 2023
$15.16M(+91.8%)
$15.16M(+11.3%)
Sep 2023
-
$13.63M(+134.6%)
Jun 2023
-
$5.81M(-12.7%)
Mar 2023
-
$6.66M(-15.8%)
Dec 2022
$7.91M
$7.91M(-50.9%)
Sep 2022
-
$16.11M(+32.3%)
Jun 2022
-
$12.18M(+82.8%)
DateAnnualQuarterly
Mar 2022
-
$6.66M(+18.5%)
Dec 2021
$5.62M(-47.8%)
$5.62M(-38.8%)
Sep 2021
-
$9.19M(-2.2%)
Jun 2021
-
$9.39M(+13.6%)
Mar 2021
-
$8.27M(-23.2%)
Dec 2020
$10.78M(-3.6%)
$10.78M(-55.8%)
Sep 2020
-
$24.39M(-29.0%)
Jun 2020
-
$34.37M(+65.6%)
Mar 2020
-
$20.75M(+85.7%)
Dec 2019
$11.18M(+149.7%)
$11.18M
Dec 2018
$4.48M(>+9900.0%)
-
Dec 2017
$0.00(0.0%)
-
Dec 2016
$0.00(0.0%)
-
Dec 2015
$0.00
-

FAQ

  • What is Royalty Pharma plc annual accounts payable?
  • What is the all-time high annual accounts payable for Royalty Pharma plc?
  • What is Royalty Pharma plc annual accounts payable year-on-year change?
  • What is Royalty Pharma plc quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly accounts payable year-on-year change?

What is Royalty Pharma plc annual accounts payable?

The current annual accounts payable of RPRX is $13.37M

What is the all-time high annual accounts payable for Royalty Pharma plc?

Royalty Pharma plc all-time high annual accounts payable is $15.16M

What is Royalty Pharma plc annual accounts payable year-on-year change?

Over the past year, RPRX annual accounts payable has changed by -$1.79M (-11.84%)

What is Royalty Pharma plc quarterly accounts payable?

The current quarterly accounts payable of RPRX is $41.41M

What is the all-time high quarterly accounts payable for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly accounts payable is $41.41M

What is Royalty Pharma plc quarterly accounts payable year-on-year change?

Over the past year, RPRX quarterly accounts payable has changed by +$19.36M (+87.78%)
On this page